In March, Sands Bethlehem hosted its first Sustainable Foods Workshop in conjunction with Las Vegas Sands’ Global Sustainability Program. Six major food and beverage suppliers participated by discussing their company sustainability practices, while providing insight during a roundtable discussion on a myriad of sustainability topics, including trends they’re seeing and challenges they are experiencing.

It’s a common misconception that the bigger and more complex a pro bono initiative is, the higher the impact will be for nonprofits, your employees, and the company itself. In fact, the biggest determinant of a program’s impact is not its scale or complexity but the quality of the match between employees’ expertise and nonprofits’ needs. Great pro bono initiatives have one thing in common – the right support for the right nonprofit at the right time.

General Motors earned the 2017 EPA ENERGY STAR® Partner of the Year — Sustained Excellence award for continued leadership in protecting the environment through superior energy efficiency. GM’s commitment to reducing energy intensity saved $73 million in energy costs last year and avoided 388,000 metric tons of carbon emissions, equivalent to the electricity use of 57,000 U.S. homes.

Gildan is proud to announce the donation and inauguration of the external newborn ward at Mario C. Rivas Hospital in San Pedro Sula, Honduras.

What started as a small project in their kitchen has now grown and expanded into their garage. To date, they have made and donated 15,000 crayons and are expanding with local partnerships like their local Boys & Girls Club and different schools in the area.

Now in its fourth year, the Bacardi Limited “Good Spirited” initiative continues to make an impact as we work together to build a more sustainable future.

Every year on April 21, MADD, as part of the Power of Parents® program, encourages parents to have critical, potentially life-saving conversations with their teens about the dangers of underage drinking and other drugs.

It can take longer to diagnose rare diseases than many common diseases. On average, rare disease diagnosis takes 7.6 years in the U.S. and 5.6 years in the UK. Rare diseases such as the primary immunodeficiency (PI) disorders Gaucher disease, Fabry disease, and Hunter syndrome can be devastating, as they are difficult to detect and equally difficult to treat.